Evidence map›Paper›PMID 34500755›Full record

ArticleMolecules (Basel, Switzerland)2021

Preliminary Insight of Pyrrolylated-Chalcones as New Anti-Methicillin-Resistant

Mohanapriya Gunasekharan, Tae-Ik Choi, Yaya Rukayadi, Muhammad Alif Mohammad Latif, Thiruventhan Karunakaran, Siti Munirah Mohd Faudzi, Cheol-Hee Kim

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Crystal structure and Hirshfeld surface analysis of 3-(3-hy-droxy-phen-yl)-1-(1Acta crystallographica. Section E, Crystallographic communications · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mohanapriya GunasekharanDepartment of Chemistry, Faculty of Science, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.
Tae-Ik ChoiDepartment of Biology, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Korea.
Yaya RukayadiNatural Medicines and Product Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.ORCID 0000-0001-7807-4462
Muhammad Alif Mohammad LatifCentre of Foundation Studies for Agricultural Science, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.ORCID 0000-0002-3345-0265
Thiruventhan KarunakaranCentre for Drug Research, Universiti Sains Malaysia, Gelugor 11800, Pulau Pinang, Malaysia.ORCID 0000-0003-4470-2656
Siti Munirah Mohd FaudziDepartment of Chemistry, Faculty of Science, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.
Cheol-Hee KimDepartment of Biology, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Korea.ORCID 0000-0002-3019-0699
Universiti Putra Malaysia · MYChungnam National University · KRUniversiti Sains Malaysia · MY

Funding

National Research Foundation of Korea 2018M3A9B8021980Universiti Putra Malaysia GP-IPS/2018/9618500
6 · The paper itself

Abstract

Bacterial infections are regarded as one of the leading causes of fatal morbidity and death in patients infected with diseases. The ability of microorganisms, particularly methicillin-resistant

Indexed as

Anti-Bacterial AgentsChalconesDose-Response Relationship, DrugMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular StructurePyrrolesStructure-Activity RelationshipAnti-Bacterial AgentsChalconesPyrrolesanti-MRSAmolecular dockingpyrrolylated-chalconessynthesiszebrafish toxicity

Identifiers

PMID34500755
PMCPMC8434082
OpenAlexW3197707076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.